WVP
FLNA

Worth Venture Partners’s Filana Therapeutics FLNA Stock Holding History

Worth Venture Partners’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-48,535
Closed -$200K – 138
2020
Q1 		$200K Sell
48,535
-183,907
-79% -$1.22M 0.12% 78
2019
Q4 		$1.49M Sell
232,442
-127,179
-35% -$220K 0.73% 21
2019
Q3 		$431K Buy
359,621
+62,998
+21% +$80.9K 0.25% 49
2019
Q2 		$359K Buy
296,623
+8,260
+3% +$9.37K 0.2% 54
2019
Q1 		$372K Buy
288,363
+280,185
+3,426% +$321K 0.21% 57
2018
Q4 		$6K Buy
+8,178
New +$9.4K ﹤0.01% 88

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Worth Venture Partners's FLNA Position: Q2 2020 in Review

Worth Venture Partners sold out of Filana Therapeutics (FLNA) in Q2 2020, closing a stake of 48,535 shares — an estimated $200K sold.

Worth Venture Partners first reported a position in FLNA in Q4 2018 and held it in 6 quarters. The position peaked at $1.49M in Q4 2019. 51 funds tracked by Wall St. Rank hold FLNA as of Q2 2020.

  • Worth Venture Partners reported no remaining Filana Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Worth Venture Partners sold 48,535 Filana Therapeutics shares in Q2 2020, an estimated $200K.
  • Worth Venture Partners first reported a position in Filana Therapeutics in Q4 2018 and held it in 6 quarters.
  • Worth Venture Partners's Filana Therapeutics position peaked at $1.49M in Q4 2019.
  • 51 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2020.

Based on Worth Venture Partners's 13F filing for Q2 2020, filed 14 Aug 2020.